Insider Transactions in Q4 2019 at Eagle Pharmaceuticals, Inc. (EGRX)
Insider Transaction List (Q4 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 25
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
15,437
-2.06%
|
$972,531
$63.57 P/Share
|
|
Oct 24
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
1,494
-0.2%
|
$92,628
$62.53 P/Share
|
|
Oct 23
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
200
-0.03%
|
$12,400
$62.58 P/Share
|
|
Oct 22
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
6,567
-0.87%
|
$407,154
$62.68 P/Share
|
|
Oct 21
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
3,849
-0.51%
|
$238,638
$62.56 P/Share
|
|
Oct 18
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
1,600
-0.21%
|
$99,200
$62.61 P/Share
|
|
Oct 17
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
13,842
-1.78%
|
$858,204
$62.58 P/Share
|
|
Oct 16
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
102
-0.01%
|
$6,324
$62.5 P/Share
|
|
Oct 15
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
3,909
-0.5%
|
$242,358
$62.63 P/Share
|
|
Oct 11
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
16,300
-2.05%
|
$978,000
$60.39 P/Share
|
|
Oct 10
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
7,829
-0.97%
|
$469,740
$60.16 P/Share
|
|
Oct 08
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
1,558
-0.19%
|
$93,480
$60.03 P/Share
|
|
Oct 07
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
4,901
-0.6%
|
$294,060
$60.11 P/Share
|